MGMT and glioma: The current study shows that the HIV-derived protein Vpr induces apoptosis in glioma cells, acts independently from MGMT expression status, is tolerated well when given intravenously, delays intracranial tumor growth and prolongs survival in a relevant pre-clinical model of high-grade glioma.